Improved survival in myeloma patients–a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden

The prevalence of multiple myeloma (MM) is increasing in Nordic countries and the rest of the western world. Patients aged ≥75 years at diagnosis constitute an increasing proportion of all MM patients, but are underrepresented in randomized clinical trials. There is an urgent need for studies of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Kari Lenita Falck, Turesson, Ingemar, Genell, Anna, Klausen, Tobias W., Knut-Bojanowska, Dorota, Redder, Louise, Sverrisdottir, Ingigerdur, Thorsen, Jonathan, Vangsted, Annette J., Blimark, Cecilie H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Plasma Cell Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230423/
https://www.ncbi.nlm.nih.gov/pubmed/36300775
http://dx.doi.org/10.3324/haematol.2021.280424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230423/
https://www.ncbi.nlm.nih.gov/pubmed/36300775
http://dx.doi.org/10.3324/haematol.2021.280424

Ejemplares similares